Signal blues

Scientist

Volumn 17, Issue 16, 2003, Pages

  Bunk, Steve ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTALARMIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; CYTOKINE RECEPTOR INHIBITOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; BEHAVIOR DISORDER; BRAIN LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DRUG INDUCED DISEASE; GENETIC SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MALIGNANT NEOPLASTIC DISEASE; MELANCHOLIA; MOLECULAR BIOLOGY; MOOD DISORDER; NEUROBIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PREDICTION; PROTEIN EXPRESSION; RELAPSE; REMISSION; REVIEW; SOCIAL PSYCHOLOGY; STRESS; SYMPTOM; THEORY;

ANIMALIA; POLYOMMATINAE;

EID: 0141628396     PISSN: 08903670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. A. Solomon, The Noonday Demon: An Atlas of Depression, New York: Scribner, 2001.
2. M. Maes et al., "Depression related disturbances in mitogen-induced lymphocyte responses and IL-1 beta and soluble IL-2 receptor production," Acta Psychiatrica Scandanavica, 84:379-86, 1991.
3. P.W. Gold, G.P. Chrousos, "Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states," Mol Psychiat, 7:254-75, 2002.
4. B.L. Hart, "Biological basis of the behavior of sick animals," Neurosci Biobehav Rev, 12:123-37, 1988.
5. S. Kent et al., "Sickness behavior as a new target for drug development," Trends Pharmacol Sci, 12:24-8, 1992.
6. Y. Pollack, R. Yirmiya, "Cytokine-induced changes in mood and behavior: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment," Int J Neuropsychopharmacol, 5:388-99, 2002.
7. L. Capuron et al., "Neurobehavioral effects of interferon-α in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions," Neuropsychopharmacol, 26:643-52, 2002.
8. L. Capuron et al., "Association of exaggerated HPA axis response to the initial injection of interferon-α with development of depression during intenferon-α therapy," Am J Psychiat, 160:1342-5, July 2003.
9. C.S. Cleeland et al., "Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer systems," Cancer, 97:2919-25, 2003.
10. C.R. Pugh et al., "Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation," Behav Brain Res, 106:109-18, 1999.
11. R. Yirmiya, "Endotoxin produces a depressive-like episode in rats," Brain Res, 711:163-74, 1996.
12. E.C. Suarez et al., "The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men," Psychosom Med, 65:362-8, 2003.